In vivo protein-DNA interactions at human DNA replication origin.
AUTOR(ES)
Dimitrova, D S
RESUMO
Protein-DNA interactions were studied in vivo at the region containing a human DNA replication origin, located at the 3' end of the lamin B2 gene and partially overlapping the promoter of another gene, located downstream. DNase I treatment of nuclei isolated from both exponentially growing and nonproliferating HL-60 cells showed that this region has an altered, highly accessible, chromatin structure. High-resolution analysis of protein-DNA interactions in a 600-bp area encompassing the origin was carried out by the in vivo footprinting technique based on the ligation-mediated polymerase chain reaction. In growing HL-60 cells, footprints at sequences homologous to binding sites for known transcription factors (members of the basic-helix-loop-helix family, nuclear respiratory factor 1, transcription factor Sp1, and upstream binding factor) were detected in the region corresponding to the promoter of the downstream gene. Upon conversion of cells to a nonproliferative state, a reduction in the intensity of these footprints was observed that paralleled the diminished transcriptional activity of the genomic area. In addition to these protections, in close correspondence to the replication initiation site, a prominent footprint was detected that extended over 70 nucleotides on one strand only. This footprint was absent from nonproliferating HL-60 cells, indicating that this specific protein-DNA interaction might be involved in the process of origin activation.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=39968Documentos Relacionados
- The pSC101 par locus alters protein-DNA interactions in vivo at the plasmid replication origin.
- In vivo protein-DNA interactions at the beta-globin gene locus.
- Protein-DNA interactions in regulation of P1 plasmid replication.
- In vivo protein-DNA interactions at hypersensitive site 3 of the human beta-globin locus control region.
- Protein-DNA interactions in vivo of an erythroid-specific, human beta-globin locus enhancer.